You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新華製藥(00719.HK)獲控股股東進一步增持414.3萬股A股
格隆匯 11-20 18:40

格隆匯11月20日丨新華製藥(00719.HK)公告,於2019年11月20日,公司獲華魯投資發展通知,華魯投資已通過深圳證券交易所交易系統競價買入方式增持若干A股股份。華魯投資為本公司控股股東華魯控股的全資子公司。現將有關進一步增持情況公告如下:

自2019年5月21日,華魯投資進一步通過深圳證券交易所交易系統以均價約人民幣7.12元/股的價格增持本公司A股股份共計414.3萬股,分別佔本公司已發行A股股份總數的約0.97%和已發行股份總數的約0.67%,增持總金額約為人民幣2948.07萬元。

進一步增持前,華魯控股直接持有本公司2.05億股A股股份,約佔本公司已發行A股股份總數的約47.99%和已發行股份總數的約32.94%,華魯控股另外通過間接控股子公司維斌有限公司持有本公司H股1779.1萬股,約佔本公司已發行總股份的2.86%。即華魯控股(包括其下屬公司)於進一步增持前合併持有本公司股份2.23億股,約佔本公司已發行總股份的35.80%。進一步增持後,華魯控股(包括其下屬公司)合併持有本公司2.09億股A股股份,分別佔本公司已發行A股股份總數的約48.96%和已發行股份總數的約33.61%。

華魯投資已完成自2019年5月21日起的6個月內通過二級市場增持本公司股份的計劃。在此期間,除本公司已披露的首次增持及進一步增持外,華魯控股及其一致行動人未再通過二級市場增持本公司股份。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account